Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Ekso Bionics Holdings (NASDAQ:EKSO) reported its Q4 earnings results on Monday, March 4, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Ekso Bionics Holdings missed estimated earnings by -100.0%, reporting an EPS of $-0.22 versus an estimate of $-0.11.
Revenue was up $1.30 million from the same period last year.
Last quarter the company beat on EPS by $0.07 which was followed by a 6.0% increase in the share price the next day.
Here's a look at Ekso Bionics Holdings's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -0.31 | -0.28 | -0.31 | |
EPS Actual | -0.24 | -0.31 | -0.33 | -0.24 |
Revenue Estimate | 4.50M | 4.35M | 2.80M | 3.94M |
Revenue Actual | 4.61M | 4.70M | 4.12M | 3.55M |
To track all earnings releases for Ekso Bionics Holdings visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: EKSO